Nevertheless, based on a wide range of strong phenotypes displayed by our slc13a5 mutants, including behavioral deficits, molecular defects, disturbed bioenergetics profile and importantly enhanced calcium events (another measure of neuronal activity), we can suggest that these mutants are a promising model of SLC13A5 epilepsy. This evidence concerns the gene SLC13A5 and epilepsy.